Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis

Diffuse alveolar hemorrhage (DAH) is a serious complication of the small vessel vasculitis syndromes and carries a high mortality. Recombinant activated factor VII (rFVIIa) is used to treat bleeding in patients with hemophilia and antibodies to factor VIII or IX. It is increasingly being used in lif...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khoulani, Dania, Rao, Bharat, Khanshour, Ammar, Kuriakose, Philip, Yessayan, Lenar
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119916/
https://ncbi.nlm.nih.gov/pubmed/25114814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/283086
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky